Week | Prednisone dose (oral) |
Week 1 | 60 mg/day |
Week 2 | 50 mg/day |
Week 3 | 40 mg/day |
Week 4 | 30 mg/day |
Week 5 | 20 mg/day |
Week 6 | 15 mg/day |
Week 7 | 10 mg/day |
Week 8 | 7.5 mg/day |
Weeks 9 to 10 (2 weeks) | 6 mg/day¶ |
Weeks 11 to 12 (2 weeks) | 5 mg/day |
Weeks 13 to 16 (4 weeks) | 4 mg/day |
Weeks 17 to 20 (4 weeks) | 4 mg/day on even days and 3 mg/day on odd days |
Weeks 21 to 24 (4 weeks) | 3 mg/day |
Weeks 25 to 28 (4 weeks) | 3 mg/day on even days and 2 mg/day on odd days |
Weeks 29 to 32 (4 weeks) | 2 mg/day |
Weeks 33 to 36 (4 weeks) | 2 mg/day on even days and 1 mg/day on odd days |
Weeks 37 to 40 (4 weeks) | 1 mg/day |
Weeks 41 to 44 (4 weeks) | 1 mg/day on even days and none on odd days |
Week 45 | Stop |
* Many factors influence the pace of systemic glucocorticoid withdrawal, including control of the underlying disease, adverse effects of glucocorticoids, patient age, clinical status, and response to prior glucocorticoid tapers. Tapers should be adjusted when there is concern for adrenal insufficiency (based on clinical symptoms and/or laboratory testing). For more information, refer to UpToDate content on glucocorticoid withdrawal and the disease-specific treatment topic.
¶ Some experts use laboratory cortisol testing to help guide the taper after reaching a physiologic glucocorticoid dose (approximately 5 to 7.5 mg of prednisone). Testing involves omitting the glucocorticoid dose on the morning of the test and measuring an endogenous cortisol level at approximately 7 to 9 AM. For more information, refer to UpToDate content on the diagnosis of adrenal insufficiency.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟